Get informed when a big investor buys or sells
+ FollowOvervalued by 92.1% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $193.41 Million |
|---|---|
| Enterprise Value | $186.57 Million |
| Annual dividend | $0.05 |
| Earnings per Share | $-0.22 |
| Beta | 1.41 |
| Outstanding Shares | 35,750,000 |
| P/E Ratio | -1.63 |
|---|---|
| PEG | -1.13 |
| Price to Sales | 2.71 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 2.5 |
| Enterprise Value to EBIT | -10.96 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.01 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Qilian International Holding Group Limited, headquartered in Gansu, China, is a pharmaceutical and chemical products manufacturer in China. It focuses on the development, manufacture, marketing and sale of licorice products, oxytetracycl...
In the latest 13F quarter on Stockcircle, 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.
Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.